Alloy is Building the World's First Fully Integrated Product Development
Organization - Read the full article
Platforms and services accelerating discovery of innovative antibody therapeutics
- Explore Antibodies & Multispecifics
Antibody DISCOVERY Platforms
Unmatched transgenic models for human antibody discovery
Our world-class, fully human in vivo discovery platforms are designed to provide exceptional strain diversity including hyperimmune mice for challenging targets and common light-chain (CLC) strains for multispecific development, with proprietary technologies that deliver high-quality, differentiated antibodies. Through our ATX-GX™ license, we offer broad access to the platform with flexible business terms enabling our partners to make life-changing medicines.
200+
110+
25+v
ANTIBODY DISCOVERY SERVICES
Your ideal antibody powered by proprietary technologies
At Alloy, we combine cutting-edge technologies with a personalized approach to antibody discovery services, backed by over 100 years of collective expertise and tailored to meet your specific needs. We de-risk your candidates at every stage using our proprietary humanized transgenic mice and integrated technology workflows, including:
- Optimized immunization and B cell enrichment strategies
- AI/ML powered clone selection
- Robust testing for binding, developability, and function.
MULTISPECIFIC ENGINEERING
Utilizing advanced capabilities
We simplify multispecific antibody discovery through an integrated platform that spans antibody discovery, engineering, and screening, helping advance high-quality therapeutic leads with greater speed and confidence.
Optimization
Antibody optimization services to hit your target product profile
We offer advanced antibody optimization workflows and strategies to ensure that your drug candidates are fine-tuned for clinical success. By applying cutting-edge tools, we rapidly engineer your lead candidates for affinity, specificity, or developability to unlock the full potential of your antibody program.
AI/ML Powered In Silico Design
From optimizing binding affinity and stability to reducing immunogenicity and improving developability, our sophisticated computational tools enables the design of next generation antibodies with precision and speed.
high-throughput expression and testing
Maximize efficiency and achieve breakthrough results by rapidly expressing and testing hundreds to thousands of variants for binding, stability, and functionality.
Advanced display platforms and technologies
We combine AI/ML designed libraries with cutting edge display platforms to rapidly select leads with improved affinity, specificity, and developability.
